Clinical Study Shows Hallucinogenic Magic Mushroom Compound Psilocybin Relieves Depression

In a small study of adults with major depressive disorder, Johns Hopkins Medicine researchers found that two doses of psilocybin, the psychedelic compound found in “magic mushrooms,” produced large reductions in depressive symptoms, when administered with supportive psychotherapy. The trial results showed that psilocybin-assisted therapy led to improvements in most of the patients, with half of the study participants achieving remission through the four-week follow-up.